Premarket movers: Mag 7 stocks are mostly higher: Alphabet is leading Magnificent 7 peers higher as technology and AI-related stocks boost the US stock futures. Meanwhile, Apple underperforms the cohort (Alphabet +2.4%, Nvidia +0.4%, Apple +0.1%, Tesla +0.5%, Amazon +0.5%, Microsoft -0.1%, Meta +0.7%). Cryptocurrency-linked stocks are rallying in premarket trading, set to extend gains, after US SEC greenlit digital versions of securities to start trading in the US. European telecom stocks sold off on Friday, following US-listed peers lower, amid concerns over competition from satellite operators and disruptive impact from agentic AI tools. Fluence Energy Inc. received another downgrade on Friday, with Jefferies cutting the energy storage company to hold from buy, citing a recent cut to the company’s outlook. Intuit shares are little changed in premarket trading, after the tax-preparation software company hosted an investor day where it gave financial targets and discussed its strategy to deliver higher growth. Analysts say the stock remains a show-me story as the company navigates the AI era. Macom Technology Solutions Holdings Inc. shares are up 2.1% in premarket trading, after BMO Capital Markets upgraded the semiconductor device company to outperform from market perform, seeing an attractive valuation in the wake of recent weakness. Netflix shares drop 2.9% in premarket trading as Wells Fargo Securities downgrades to underweight from equal-weight, citing “worrying” engagement trends. Nvidia Corp. Chief Executive Officer Jensen Huang expects to sell twice as many chips in the coming year, fueled by the spread of artificial intelligence across different industries. Stubhub shares gain 3.5% in premarket trading as Citi upgrades to buy from neutral, citing “robust” third-quarter trends. . Tyson Foods shares are up 1.4% ahead of the bell as JPMorgan upgrades the meat producer to overweight from neutral. Xenon shares tumble 27% in premarket trading Friday after the bio-pharmaceutical firm voluntarily paused enrollment in clinical studies of major depressive disorder (MDD) and bipolar depression (BPD).